News
Enfortumab vedotin with pembrolizumab for untreated unresectable or metastatic urothelial cancer when platinum-based chemotherapy is suitable [ID6332] Draft guidance Technology appraisal guidance 29 ...
Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for targeted treatments and achieving long-term remission.
A prospective registry study found a greater risk for infections associated with JAK inhibitors in adolescents and adults with moderate to severe atopic dermatitis compared with biologics.
Ruxolitinib 1.5% cream significantly reduces pruritus and lesion severity among adults with prurigo nodularis for up to 12 weeks of treatment.
It's one thing to experience difficulty with locking moisture in your skin from time to time, but if the occasional itchiness ...
Patients with suspected eyelid allergic contact dermatitis can benefit from patch testing beyond common allergens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results